跳至主要内容
临床试验/NCT05553561
NCT05553561招募中不适用

Therapeutic Effect of Intense Regulated Pulse Light in Patients With Dry Eye Disease

Menoufia University1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
34
试验地点
1
主要终点
Tear Meniscus Height

研究概览

简要总结

The aim of this study is to assess the effect of intense regulated pulse light (IRPL) on the treatment of Dry eye.

详细描述

Dry eye disease is a common ocular condition that needs prompt diagnosis and careful treatment interventions. If left untreated, it can lead to numerous sight threatening complications, including ulceration of the cornea, blepharitis, alterations of the tear film, conjunctivitis, and in severe cases, significant drying of the eye may lead to scarring, thinning, and even perforation of the cornea.

Intense pulsed light (IPL) therapy is a new treatment strategy for treatment of MGD by inducing the restoration of the normal activity of the meibomian glands. In fact, IPL has been used for treating the patients with facial telangiectasias and erythema of rosacea and also resulted in improvement in ocular surface health.

Evaporative form is the commonest form of DED and it is mainly caused by meibomian glands dysfunction (MGD). The usual traditional treatment options for MGD include warm compresses, expression of meibomian glands (MG), anti-inflammatory drugs, and lubricant eye drops.

The aim of this study is to assess the effect of intense regulated pulse light (IRPL) on the treatment of Dry eye.

The study included 34 patients with moderate to severe evaporative dry eye. The symptoms will be assessed with the Dry Eye-Related Quality of Life Score (DEQ-5) Questionnaire. The tear film will be assessed through MediWorks D130+S390L (WDR) which is a device attached to the slit lamp for non-invasive examination of tear film.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with moderate to severe dry eye disease & clinicaily significant signs of meibomian gland dysfunction

排除标准

  • Use systemic medications known to affect the eye two weeks prior to baseline assessment.
  • Pregnancy.
  • Ocular surgery or dermatologic treatments in the previous Two months or during the treatment period.
  • Implants, tattoos, or pigmented lesions in the treatment area.
  • Contraindications to IPL therapy, including the use of photosensitive medications.

结局指标

主要结局

Tear Meniscus Height

时间窗: before treatment

assessment of tear film through MediWorks device attached to the slitlamp

Change in Tear Meniscus Height

时间窗: Within 1 month after completion of treatment

assessment of tear film through MediWorks device attached to the slitlamp

Lipid layer thickness

时间窗: before treatment

assessment of tear film through MediWorks device attached to the slitlamp

Non-invasive tear film break up time

时间窗: before treatment

assessment of tear film through MediWorks device attached to the slitlamp

Change in Non-invasive tear film break up time

时间窗: Within 1 month after completion of treatment

assessment of tear film through MediWorks device attached to the slitlamp

Change in Lipid layer thickness

时间窗: Within 1 month after completion of treatment

assessment of tear film through MediWorks device attached to the slitlamp

Change in Meibomian glands % loss grading

时间窗: Within 1 month after completion of treatment

assessment of tear film through MediWorks device attached to the slitlamp

Change in patient's quality of life affection

时间窗: Within 1 month after completion of treatment

The effect of dry eye on the patient's Quality Of Life was evaluated with the aid of Dry Eye-Related Quality of Life Score (DEQ-5) Questionnaire.

Meibomian glands % loss grading

时间窗: before treatment

assessment of tear film through MediWorks device attached to the slitlamp

patient's quality of life affection

时间窗: before treatment

The effect of dry eye on the patient's Quality Of Life was evaluated with the aid of Dry Eye-Related Quality of Life Score (DEQ-5) Questionnaire.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rofaida Mostafa Mansour Serag EL Deen

Ophthalmologist at Menoufia university hospitals

Menoufia University

研究点 (1)

Loading locations...

相似试验